GO:0086080 protein binding involved in heterotypic cell-cell adhesion: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086080 describes a molecular function: binding to a protein or protein complex that contributes to adhesion between two different cell types.
• Heterotypic cell-cell adhesion is central to immune surveillance, hematopoiesis, thrombosis, and cancer progression.
• Key molecular players include immunoglobulin superfamily members such as ALCAM/CD166 and CRTAM-Necl2 interactions.
• Selectin-PSGL-1 binding is a paradigm of heterotypic adhesion in thrombus formation and cancer.
• Erythroblast-macrophage contact involves a 30-kD heparin-binding protein and supports erythroid proliferation and maturation.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of heterotypic adhesion molecules in disease.
Description
GO:0086080, protein binding involved in heterotypic cell-cell adhesion, is a molecular function term that captures the binding event between proteins or protein complexes on two different cell types, leading to their adhesion. This function is distinct from homotypic adhesion because it specifically requires interaction between non-identical cell types, such as T cells and antigen-presenting cells, or erythroblasts and macrophages. Heterotypic adhesion is essential for immune synapse formation, hematopoietic development, and platelet-thrombus interactions. Researchers study GO:0086080 to understand how cell-cell contacts are initiated and stabilized at the molecular level, and how disruption of these contacts contributes to disease. The term is supported by experimental evidence from immunoglobulin superfamily interactions, selectin-ligand binding, and fungal adhesin studies.
protein binding involved in heterotypic cell-cell adhesion At A Glance
| GO ID | GO:0086080 |
|---|---|
| GO term | protein binding involved in heterotypic cell-cell adhesion |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to a protein or protein complex contributing to adhesion of two different types of cells |
| Biological context | Immune cell interactions, hematopoiesis, thrombosis, cancer progression |
| Example molecules | ALCAM/CD166, CRTAM, Necl2, PSGL-1, selectins, Fig2p |
| Experimental evidence | Immunoglobulin superfamily binding, selectin-ligand interactions, fungal adhesin studies |
What Is GO:0086080?
In simple terms, GO:0086080 is the function of a protein binding to another protein or protein complex in a way that sticks two different types of cells together. The QuickGO definition states: Binding to a protein or protein complex contributing to the adhesion of two different types of cells. This is a molecular_function term, meaning it describes the activity of a gene product rather than a whole biological process or cellular structure. It is narrower than general cell adhesion because it requires heterotypic (different cell type) interactions and is mediated by direct protein-protein binding.
Why Is protein binding involved in heterotypic cell-cell adhesion Important in Cell Biology?
GO:0086080 matters because heterotypic cell-cell adhesion is a fundamental mechanism by which different cell types communicate, coordinate immune responses, and maintain tissue architecture. Dysregulation of these binding events is implicated in cancer metastasis, thrombotic disease, and defective hematopoiesis. Understanding the molecular basis of heterotypic adhesion enables researchers to target specific protein-protein interfaces for therapeutic intervention and to design better in vitro models of human disease.
• Enables immune cell interactions such as NK cell and CD8+ T cell adhesion to target cells via CRTAM-Necl2.
• Supports erythroid proliferation and maturation through erythroblast-macrophage contact.
• Contributes to thrombus formation and cancer progression via selectin-PSGL-1 binding.
• Regulates cell migration and adhesion through ALCAM/CD166 in cancer models.
• Provides a molecular target for anti-adhesion therapies in inflammation and metastasis.
• Facilitates dendritic cell interactions at the interface of innate and acquired immunity.
• Enables high-throughput interrogation of cellular fate decisions using multiplexed cellular communities.
• Offers a model for engineering light-controlled cell adhesion using BcLOV4.
• Informs studies of fungal mating cell integrity through adhesin Fig2p.
• Supports development of CRISPR-based disease models targeting adhesion molecules.
Molecular Mechanism of protein binding involved in heterotypic cell-cell adhesion
Initial Recognition and Binding
In simple terms: Two different cell types first recognize each other when a protein on one cell binds a protein on the other cell.
The molecular function GO:0086080 begins with direct binding between a protein or protein complex on one cell and a partner on a different cell type. For example, CRTAM on activated NK cells and CD8+ T cells binds Necl2 to induce heterotypic cell adhesion. Similarly, selectins bind PSGL-1 to mediate adhesion between leukocytes and platelets or endothelium. This binding is typically low-affinity and fast, allowing dynamic regulation.
Adhesion Stabilization and Signaling
In simple terms: After the first contact, the adhesion is strengthened and signals are sent into the cells.
Following initial binding, the interaction stabilizes and can trigger intracellular signaling. ALCAM/CD166 modulation affects cell adhesion and migration, indicating that heterotypic binding is not merely mechanical but also regulatory. In erythroblast-macrophage contact, a 30-kD heparin-binding protein is involved in promoting erythroid proliferation and maturation, showing that adhesion can deliver growth and differentiation signals.
Dynamic Regulation and Turnover
In simple terms: The adhesion can be turned on and off, and proteins can be added or removed from the cell surface.
Heterotypic adhesion is dynamically regulated. Light-controlled promiscuous cell adhesion through the plasma membrane-binding protein BcLOV4 demonstrates that adhesion can be engineered and switched on demand. In fungal mating, the adhesin Fig2p is required for maintenance of mating cell integrity, illustrating that adhesion molecules must be actively maintained.
Cofactors and Structural Requirements
In simple terms: Certain helper molecules and structural features are needed for the binding to work.
The 30-kD heparin-binding protein involved in erythroblast-macrophage contact requires heparin-binding properties, suggesting glycosaminoglycan cofactors may modulate heterotypic adhesion. Immunoglobulin superfamily members such as ALCAM/CD166 and CRTAM/Necl2 rely on extracellular immunoglobulin domains for binding specificity. Selectin-PSGL-1 interactions depend on post-translational modifications such as sulfation and sialylation.
Downstream Cellular Consequences
In simple terms: The adhesion changes what the cells do next, such as divide, migrate, or activate.
Heterotypic adhesion via GO:0086080 can drive proliferation, maturation, migration, or activation. Erythroblast-macrophage contact promotes erythroid proliferation and maturation. CRTAM-Necl2 interaction induces cell adhesion on activated NK cells and CD8+ T cells, contributing to immune activation. ALCAM/CD166 modulation influences cell adhesion and migration, with implications for metastasis.
Key Genes Involved in GO:0086080 protein binding involved in heterotypic cell-cell adhesion
The following genes and proteins are experimentally linked to heterotypic cell-cell adhesion functions and provide tractable targets for CRISPR modeling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALCAM/CD166 | Immunoglobulin superfamily adhesion molecule | Modulates cell adhesion and migration in cancer |
| CRTAM | Ig superfamily receptor on activated NK and CD8+ T cells | Binds Necl2 to induce heterotypic adhesion |
| Necl2 | Ig superfamily ligand for CRTAM | Mediates adhesion with CRTAM-expressing cells |
| PSGL-1 | Selectin ligand on leukocytes | Key component in thrombus formation and cancer progression |
| Selectins | Endothelial and platelet adhesion receptors | Bind PSGL-1 in heterotypic adhesion |
| Fig2p | Fungal adhesin | Maintains mating cell integrity |
| BcLOV4 | Light-controlled plasma membrane-binding protein | Engineers promiscuous cell adhesion |
| 30-kD heparin-binding protein | Erythroblast-macrophage contact mediator | Promotes erythroid proliferation and maturation |
| Dendritic cell surface molecules | Antigen presentation interface | Operate at innate/acquired immunity interface |
| Integrins (context-dependent) | Cell adhesion receptors | Often cooperate in heterotypic adhesion |
| Cadherins (context-dependent) | Calcium-dependent adhesion proteins | May contribute to heterotypic contacts |
| Immunoglobulin superfamily members | Diverse adhesion receptors | Central to heterotypic binding |
| Chemokine receptors | Migration and adhesion regulation | Modulate heterotypic interactions |
| Mucins (e.g., PSGL-1-like) | Glycoprotein ligands | Support selectin binding |
| Heparan sulfate proteoglycans | Cofactors for heparin-binding proteins | Modulate erythroblast-macrophage contact |
How Is protein binding involved in heterotypic cell-cell adhesion Regulated?
Heterotypic cell-cell adhesion is regulated at multiple levels. Surface expression of adhesion molecules such as ALCAM/CD166 can be modulated to alter adhesion and migration. Selectin-PSGL-1 interactions are regulated by post-translational modifications and shedding. Light-controlled systems like BcLOV4 demonstrate that adhesion can be engineered to be switchable, highlighting the dynamic nature of these interactions. In erythroblast-macrophage contact, a 30-kD heparin-binding protein is involved, suggesting that local factor availability regulates adhesion.
protein binding involved in heterotypic cell-cell adhesion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALCAM/CD166 | Cancer metastasis | Knockout and overexpression in cancer cell lines |
| PSGL-1 | Thrombosis and cancer progression | Point mutation of selectin-binding site |
| CRTAM | Immune surveillance defects | Knockout in NK and CD8+ T cells |
| 30-kD heparin-binding protein | Ineffective erythropoiesis | Knockdown in erythroblast-macrophage co-cultures |
| Fig2p | Fungal mating defects | Knockout in fungal models |
Cancer Metastasis and Progression
Heterotypic adhesion molecules such as ALCAM/CD166 modulate cell adhesion and migration, and their dysregulation is linked to cancer metastasis. Selectin-PSGL-1 interactions contribute to cancer progression and thrombus formation, making them attractive targets for anti-metastatic strategies.
Thrombotic and Cardiovascular Disease
The interaction of selectins and PSGL-1 is a key component in thrombus formation, and disruption of this heterotypic adhesion can affect platelet-leukocyte aggregates.
Hematological Disorders
Erythroblast-macrophage contact promotes erythroid proliferation and maturation; defects in this heterotypic adhesion may contribute to ineffective erythropoiesis.
Immune Dysfunction
CRTAM-Necl2 interaction induces adhesion on activated NK cells and CD8+ T cells, and impaired heterotypic adhesion may affect immune surveillance. Dendritic cells operating at the innate/acquired immunity interface rely on such interactions.
From protein binding involved in heterotypic cell-cell adhesion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is ALCAM/CD166 required for heterotypic adhesion? | CRISPR knockout in cancer cell lines |
| Does a point mutation in PSGL-1 abolish selectin binding? | Point-mutation knock-in |
| Can CRTAM-Necl2 interaction be tagged for imaging? | Tagged knock-in of CRTAM |
| Does overexpression of BcLOV4 induce light-controlled adhesion? | Overexpression model |
| What is the role of the 30-kD heparin-binding protein in erythropoiesis? | Knockout in erythroid progenitor cells |
| How do dendritic cells mediate heterotypic adhesion? | Knockout of candidate surface molecules |
How to Study the protein binding involved in heterotypic cell-cell adhesion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Multiplexed cellular community arrays | Cellular fate decisions | High-throughput adhesion studies |
| Light-controlled adhesion assay | Dynamic cell adhesion | BcLOV4 engineering |
| Flow cytometry adhesion assay | Cell-cell binding events | CRTAM-Necl2 interaction |
| CRISPR knockout screening | Gene requirement for adhesion | Cancer and immune models |
| Proteomics | Protein interaction partners | Adhesion complex identification |
| Live-cell imaging | Real-time adhesion dynamics | Heterotypic contact visualization |
| Co-culture assays | Erythroid proliferation and maturation | Erythroblast-macrophage contact |
| Fungal mating assays | Mating cell integrity | Fig2p function |
High-Throughput Cellular Community Arrays
High-throughput arrays of multiplexed cellular communities allow interrogation of cellular fate decisions driven by heterotypic adhesion. These platforms enable systematic testing of adhesion molecule combinations.
Live-Cell Imaging and Light Control
Light-controlled promiscuous cell adhesion using BcLOV4 provides a powerful method to visualize and manipulate heterotypic adhesion in real time.
Flow Cytometry and Adhesion Assays
Flow cytometry-based adhesion assays can quantify binding between different cell types, as demonstrated for CRTAM-Necl2 interactions.
CRISPR Screening and Proteomics
CRISPR library screening combined with proteomics can identify novel protein-protein interactions underlying heterotypic adhesion.
How CRISPR Can Be Used to Study GO:0086080 protein binding involved in heterotypic cell-cell adhesion
Knockout
CRISPR knockout of genes such as ALCAM/CD166 or CRTAM can test their requirement for heterotypic cell-cell adhesion. Knockout models are essential for causal inference in adhesion biology.
Point Mutation
Point mutations can be introduced into adhesion molecules like PSGL-1 to dissect specific binding interfaces with selectins. This approach reveals residues critical for heterotypic adhesion.
Knock-in
Knock-in of tags or reporters into endogenous loci, such as CRTAM or Necl2, enables visualization and tracking of heterotypic adhesion complexes.
Overexpression
Overexpression of adhesion molecules like BcLOV4 or ALCAM/CD166 can drive gain-of-function phenotypes and test sufficiency in heterotypic adhesion.
How EDITGENE Supports protein binding involved in heterotypic cell-cell adhesion Research
Researchers studying protein binding involved in heterotypic cell-cell adhesion-related genes often need to determine whether a candidate gene is causally involved in adhesion, migration, or disease progression. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for protein binding involved in heterotypic cell-cell adhesion research.
Frequently Asked Questions About protein binding involved in heterotypic cell-cell adhesion
What is GO:0086080?
GO:0086080 is a molecular function term describing binding to a protein or protein complex that contributes to adhesion between two different types of cells.
What genes are involved in heterotypic cell-cell adhesion?
Key genes include ALCAM/CD166, CRTAM, Necl2, PSGL-1, selectins, and Fig2p.
How is heterotypic cell-cell adhesion studied?
It is studied using flow cytometry, live-cell imaging, CRISPR screens, and multiplexed cellular community arrays.
What diseases involve heterotypic cell-cell adhesion?
Cancer metastasis, thrombosis, hematological disorders, and immune dysfunction are linked to heterotypic adhesion.
What is the difference between homotypic and heterotypic adhesion?
Homotypic adhesion is between identical cell types, while heterotypic adhesion is between different cell types, as defined by GO:0086080.
Can CRISPR be used to study heterotypic cell-cell adhesion?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect adhesion mechanisms.
What is the role of PSGL-1 in heterotypic adhesion?
PSGL-1 binds selectins and is a key component in thrombus formation and cancer progression.
How does CRTAM mediate heterotypic adhesion?
CRTAM on activated NK cells and CD8+ T cells binds Necl2 to induce cell adhesion.
What is the role of ALCAM/CD166 in cell adhesion?
ALCAM/CD166 is an immunoglobulin superfamily member that modulates cell adhesion and migration.
What experimental models are available for heterotypic adhesion research?
Models include knockout cell lines, point-mutation knock-ins, tagged knock-ins, overexpression lines, and CRISPR library screens.
Conclusion
GO:0086080, protein binding involved in heterotypic cell-cell adhesion, is a molecular function that underpins critical interactions between different cell types in immunity, hematopoiesis, thrombosis, and cancer. Understanding its mechanisms through CRISPR-based models and high-throughput methods offers new opportunities for therapeutic intervention. EDITGENE provides comprehensive CRISPR services to accelerate research on this important adhesion function.
References
- 1. Veerasubramanian N et al.. 2025. Light-Controlled Promiscuous Cell Adhesion through the Plasma Membrane-Binding Protein BcLOV4.. Bioconjug Chem 36(10):2210-2219 PMID: 40977303
- 2. von Lersner A et al.. 2019. Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.. Clin Exp Metastasis 36(2):87-95 PMID: 30778704
- 3. Hanspal M et al.. 1994. The association of erythroblasts with macrophages promotes erythroid proliferation and maturation: a 30-kD heparin-binding protein is involved in this contact.. Blood 84(10):3494-504 PMID: 7949103
- 4. Figdor CG. 2003. Molecular characterization of dendritic cells operating at the interface of innate or acquired immunity.. Pathol Biol (Paris) 51(2):61-3 PMID: 12801801
- 5. Chen S et al.. 2016. Interrogating cellular fate decisions with high-throughput arrays of multiplexed cellular communities.. Nat Commun 7:10309 PMID: 26754526
- 6. Arase N et al.. 2005. Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells.. Int Immunol 17(9):1227-37 PMID: 16091383
- 7. Kappelmayer J et al.. 2017. The Interaction of Selectins and PSGL-1 as a Key Component in Thrombus Formation and Cancer Progression.. Biomed Res Int 2017:6138145 PMID: 28680883
- 8. Zhang M et al.. 2002. Maintenance of mating cell integrity requires the adhesin Fig2p.. Eukaryot Cell 1(5):811-22 PMID: 12455698
